• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VCL+ VIO 27IN 1 S/A CT-2; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VCL+ VIO 27IN 1 S/A CT-2; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Model Number VCP335H
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/08/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).This is a combination product, and the event has been reviewed for both the suture and the triclosan.(b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.(b)(4).
 
Event or Problem Description
It was reported that a patient underwent a cholecystectomy on (b)(6) 2020 and suture was used.During the procedure, the needle broke into 2 parts.Both parts were retrieved.There were no adverse patient consequences reported.No additional information was provided.
 
Additional Manufacturer Narrative
(b)(4).Date sent to the fda: 10/19/2021.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device plbbmxs0 number, and no non-conformances were identified.Trade name: irgacare®.Active ingredient(s): triclosan.Dosage form: suture/solid/parenteral: strength: 275g/m.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VCL+ VIO 27IN 1 S/A CT-2
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
MDR Report Key11959268
Report Number2210968-2021-05346
Device Sequence Number19895304
Product Code GAM
UDI-Device Identifier10705031052437
UDI-Public10705031052437
Combination Product (Y/N)Y
Initial Reporter CountryIT
PMA/510(K) Number
K132580
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 10/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2022
Device Model NumberVCP335H
Device Catalogue NumberVCP335H
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/06/2020
Supplement Date Received by Manufacturer10/19/2021
Initial Report FDA Received Date06/08/2021
Supplement Report FDA Received Date10/19/2021
Patient Sequence Number1
Patient Age63 YR
-
-